Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 6435040, 7 pages
http://dx.doi.org/10.1155/2016/6435040
Research Article

Effects of Yishen Pinggan Recipe on Renal Protection and NF-κB Signaling Pathway in Spontaneously Hypertensive Rats

1Department of Traditional Chinese Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China
2Emergency Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China
3Central Laboratory and Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China

Received 2 November 2015; Revised 5 February 2016; Accepted 11 February 2016

Academic Editor: Elia Ranzato

Copyright © 2016 Guodong Luo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Lisheng, Hypertension, People Health Publishing House, Beijing, China, 2001.
  2. J. G. Porush, “Hypertension and chronic renal failure: the use of ACE inhibitors,” American Journal of Kidney Diseases, vol. 31, no. 1, pp. 177–184, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. D. He, S. Zhuo, Z. Chen et al., “Effects of Xingding injection on mild to moderate proteinuria in hypertensive renal damages,” Chinese Journal of Integrated Traditional and Western Nephrology, vol. 7, no. 8, pp. 415–417, 2006. View at Google Scholar
  4. Y. Hu, J. Chen, K. Li et al., “Clinical study of Yishenjiangya in early renal damages of hypertension,” Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, vol. 8, no. 5, pp. 517–519, 2010. View at Google Scholar
  5. L. Han, Y. Ma, J.-G. Qin et al., “The renal protective effect of jiangya tongluo formula, through regulation of adrenomedullin and angiotensin II, in rats with hypertensive nephrosclerosis,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 428106, 9 pages, 2015. View at Publisher · View at Google Scholar
  6. Z. Hu, L. Liu, X. Zhu et al., “Yishen Pinggan method in treating early renal damage in hypertension,” Jilin Journal of Traditional Chinese Medicine, vol. 28, no. 7, pp. 490–491, 2008. View at Google Scholar
  7. J. Sun, Animal Experimental Method, People's Health Publishing House, Beijing, China, 2004.
  8. H. Yang, T. Jiang, and X. Song, “Relationship between CRP, IL-6, TNF-alpha and diabetic nephropathy,” Beijing Medical Journal, vol. 33, no. 4, pp. 289–291, 2011. View at Google Scholar
  9. A. Nakamura, T. Kohsaka, and E. J. Johns, “Differential regulation of interleukin-6 production in the kidney by the renal sympathetic nerves in normal and spontaneously hypertensive rats,” Journal of Hypertension, vol. 11, no. 5, pp. 491–497, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. K. C. Das, Y. Lewis-Molock, and C. W. White, “Thiol modulation of TNFα and IL-1 induced MnSOD gene expression and activation of NF-κB,” Molecular and Cellular Biochemistry, vol. 148, no. 1, pp. 45–57, 1995. View at Publisher · View at Google Scholar
  11. P. Zhu, H. Lin, C. Sun et al., “Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats,” Molecular Medicine Reports, vol. 5, no. 3, pp. 655–662, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Sun, Y.-H. Gao, D.-K. Tian et al., “Inflammation of different tissues in spontaneously hypertensive rats,” Sheng li xue bao: [Acta physiologica Sinica], vol. 58, no. 4, pp. 318–323, 2006. View at Google Scholar · View at Scopus
  13. D.-J. Li, R. G. Evans, Z.-W. Yang et al., “Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension,” Hypertension, vol. 57, no. 2, pp. 298–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Goebeler, R. Gillitzer, K. Kilian et al., “Multiple signaling pathways regulate NF-κB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells,” Blood, vol. 97, no. 1, pp. 46–55, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. G. K. Rangan, Y. Wang, Y.-C. Tay, and D. C. Harris, “Inhibition of NFκB activation with antioxidants is correlated with reduced cytokine transcription in PTC,” American Journal of Physiology—Renal Physiology, vol. 277, no. 5, pp. F779–F789, 1999. View at Google Scholar
  16. N. Tomita, R. Morishita, H. Y. Lan et al., “In vivo administration of a nuclear transcription factor-κB decoy suppresses experimental crescentic glomerulonephritis,” Journal of the American Society of Nephrology, vol. 11, no. 7, pp. 1244–1252, 2000. View at Google Scholar · View at Scopus
  17. X. Zhu, X. Liang, Z. Hu, X. Chang, and L. Liu, “Effect of Yishen Pinggan Decoction on blood pressure, renal function and vascular endothelial function among patients with early hypertensive renal damages,” Chinese Traditional Patent Medicine, vol. 32, no. 4, pp. 544–547, 2010. View at Google Scholar
  18. X. Wu, C. Yang, J. Yu et al., “Roles of inflammation in hypertensive renal damages,” Journal of Hypertension, vol. 11, no. 1, pp. 16–18, 2003. View at Google Scholar
  19. A. A. Elmarakby, J. E. Quigley, D. M. Pollock, and J. D. Imig, “Tumor necrosis factor α blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension,” Hypertension, vol. 47, no. 3, pp. 557–562, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. K.-I. Kim, J.-H. Lee, H.-J. Chang et al., “Association between blood pressure variability and inflammatory marker in hypertensive patients,” Circulation Journal, vol. 72, no. 2, pp. 293–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Mazor, O. Itzhaki, S. Sela et al., “Tumor necrosis factor-α: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension,” Hypertension, vol. 55, no. 2, pp. 353–362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. H. Kim, I. S. Ha, C.-I. Hwang et al., “Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-κB in immune complex kidney disease,” Kidney International, vol. 66, no. 5, pp. 1826–1837, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Ghosh and D. Baltimore, “Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB,” Nature, vol. 344, no. 6267, pp. 678–682, 1990. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kagami, T. Kuhara, K. Okada, Y. Kuroda, W. A. Border, and N. A. Noble, “Dual effects of angiotensin-II on the plasminogen/plasmin system in rat mesangial cells,” Kidney International, vol. 51, no. 3, pp. 664–671, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Xiaoyan, Study of Berberine on the Regulation of NF-κB Signaling Pathway and Its Anti-Diabetic Kidney Injuries Effects, Sun Yat-sen University, Guangzhou, China, 2009.